Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Will Novavax Stock Ever Reach Its All-Time High Again?


Novavax (NASDAQ: NVAX) investors are no strangers to tragedy. On Feb. 9 in 2021, shares of the coronavirus vaccine developer hit their all-time high of $331.68. Now, the stock trades at around $50.

But for the first time, the biotech is both profitable and growing. Are longtime shareholders doomed to heavy losses forever, or will Novavax return to its glory days?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments